Cargando…
A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity
Oral medications for the treatment of dystonia are not established. Currently, symptoms of focal dystonia are managed with botulinum toxin injections into the affected muscles. However, the injection effects are short-lived and not beneficial for all patients. We recently reported significant clinic...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208333/ https://www.ncbi.nlm.nih.gov/pubmed/30382161 http://dx.doi.org/10.1038/s41598-018-34553-x |